atopic dermatitis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

28 Jul 2017 14:34 News

Sanofi and Regeneron Pharmaceuticals have announced that the US FDA has approved Dupixent (dupilumab) injection, which is the first targeted biologic therapy for adults suffering from moderate-to-severe atopic dermatitis. more

29 Mar 2017 12:08 News

An upcoming merger agreement between Pfizer and Anacor, worth around $5.2bn, is set to boost the companies’ pipeline candidates in the atopic dermatitis space, according to GlobalData more

3 Jun 2016 09:50 News